Login to Your Account

The TRICs up Lung Cancer's Sleeve

With Unique MOA, HER4 Joins EGFR Family Cancer Targets

By Anette Breindl
Science Editor

Thursday, February 7, 2013
Studying cancer cells that survive chemotherapy treatment, scientists from Roche AG subsidiary Genentech Inc. have implicated a member of the human epidermal growth factor receptor, or HER, family in such treatment resistance.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription